Readministration of gefitinib in a responder after treatment discontinuation due to gefinitib-related interstitial lung disease: a case report
© Takamochi et al; licensee BioMed Central Ltd. 2007
Received: 29 August 2007
Accepted: 17 November 2007
Published: 17 November 2007
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting firstname.lastname@example.org.
|29 Aug 2007||Submitted||Original manuscript|
|Resubmission - Version 2|
|Submitted||Manuscript version 2|
|31 Aug 2007||Author responded||Author comments - Kazuya Takamochi|
|Resubmission - Version 3|
|31 Aug 2007||Submitted||Manuscript version 3|
|Resubmission - Version 4|
|Submitted||Manuscript version 4|
|Resubmission - Version 5|
|Submitted||Manuscript version 5|
|11 Oct 2007||Reviewed||Reviewer Report - Michael Keppen|
|15 Oct 2007||Reviewed||Reviewer Report - Gregory Riely|
|26 Oct 2007||Author responded||Author comments - Kazuya Takamochi|
|Resubmission - Version 6|
|26 Oct 2007||Submitted||Manuscript version 6|
|17 Nov 2007||Editorially accepted|
|17 Nov 2007||Article published||10.1186/1752-1947-1-138|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting email@example.com. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.